Loading candles…
Ambalal Sarabhai Enterprises Ltd. is an Indian conglomerate engaged primarily in the pharmaceuticals and electronics industries. The company manufactures and markets pharmaceutical products and active pharmaceutical ingredients (APIs), alongside professional electronic instruments and laboratory equipment. It operates through a network of subsidiaries and joint ventures within India. The company has historical significance as an early and leading name in the Indian chemical and drug industry. Further details regarding its incorporation, founders, key management, listings, and headquarters are not specified.
This page is a live market overview for AMBALAL SARABHAI ENT L (AMBALALSA) on the NSE. As a listed security, AMBALAL SARABHAI ENT L is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for AMBALALSA before placing trades on tick2trade.
As of the latest feed, AMBALALSA last traded at ₹40.58 on NSE, up ₹1.93 (4.99%) from the previous close of ₹38.65. Today's session range is ₹38.8 – ₹40.58, against a 52-week band of ₹30.15 – ₹49.98. Traded volume today stands at 56.00K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for AMBALALSA in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether AMBALALSA is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for AMBALAL SARABHAI ENT L before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in AMBALALSA. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated AMBALALSA option chain page linked from this overview.
| Monthly F&O expiry |
| 30 Jan 2026 |
| Expiry | Monthly F&O expiry | 27 Feb 2026 |
| Holiday | Republic Day — market closed | 26 Jan 2026 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.